查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2108225

2035年前的藥品賦形劑市場分析和預測：按類型、產品、技術、應用、形式、材料類型、工藝、最終用戶和功能分類。

Pharmaceutical Excipients Market Analysis and Forecast to 2035: Type, Product, Technology, Application, Form, Material Type, Process, End User, Functionality
出版日期: | 出版商: Global Insight Services | 英文 350 Pages | 商品交期: 3-5個工作天內

價格
簡介目錄

全球藥品賦形劑市場預計將從2025年的39億美元成長到2035年的65億美元，複合年成長率（CAGR）為5.3%。這一成長主要受藥品產量增加、複雜製劑應用日益廣泛以及口服、注射和生技藥品中功能性成分需求不斷成長的推動。根據美國食品藥物管理局（FDA）2025年更新的非活性成分食品藥物管理局（IID），資料庫資料庫數千種用於FDA核准藥物的非活性成分，凸顯了輔料在藥物研發中的廣泛作用。緩釋製劑、兒童製劑和標靶藥物製劑的進步進一步推動了對先進輔料的需求。

藥品賦形劑市場的「類型」細分市場包括粘合劑、稀釋劑、崩壞、潤滑劑、敷料、調味劑、防腐劑、著色劑和溶劑。其中，粘合劑、稀釋劑和崩壞在片劑和膠囊製劑中發揮著至關重要的作用，由於它們能夠提高藥物的穩定性、可壓性和生物利用度，因此佔了較大的市場佔有率。包衣劑也日益重要，因為它們能夠控制釋放、保護活性成分並改善產品外觀。溶劑、防腐劑和調味劑也因其在液體製劑和患者友好型給藥系統中的日益廣泛應用而保持著穩定的需求。製劑技術的進步和對複雜藥物需求的成長進一步推動了輔料研發的創新。

市場區隔
類型 粘合劑、稀釋劑、崩壞、潤滑劑、塗料、香料、防腐劑、著色劑、溶劑等。
產品 有機化學品、無機化學品及其他
科技 奈米科技、微膠囊化及其他
目的 口服製劑、外用製劑、注射製劑、其他
形式 固體、液體、半固體及其他
材料類型 聚合物、醣類、礦物質、明膠及其他
過程 製粒、直接壓片等
最終用戶 製藥公司、生物製藥公司、契約製造組織及其他
功能 控釋、即時釋、緩釋等。

藥品賦形劑市場按應用領域分類，包括口服製劑、外用製劑和注射製劑。口服製劑因其高滲透率、便利性、患者遵守用藥和成本效益，成為最大的應用領域。片劑、膠囊和口服固體製劑產量的增加推動了對功​​能性輔料的需求。由於生物製藥、疫苗和注射劑的需求不斷成長，注射製劑市場也呈現顯著成長，這些產品需要高品質的輔助材料來確保穩定性和安全性。外用製劑也不斷擴展，其在皮膚科、創傷護理和藥物遞送領域的應用日益廣泛。全球活性化的製藥生產為所有應用領域的市場擴張提供了支持。

區域概覽

到2025年，北美將佔全球藥品賦形劑市場最大佔有率，這主要得益於其成熟的製藥生產系統、先進的製劑技術和創新的給藥系統帶來的強勁需求。該地區匯聚了許多領先的企業和輔料生產商，他們持續投資於片劑、膠囊劑、注射劑和生物製藥多功能輔料的研發。學名藥產量的增加、生物製藥和專科藥物的日益普及以及藥品品質監管標準的嚴格性，都進一步推動了市場成長。此外，持續的研發投入，以及新型輔料在提高藥物穩定性、生物利用度和患者依從性方面的應用不斷拓展，也鞏固了北美在全球藥品賦形劑市場的主導地位。

亞太地區預計將成為醫藥輔料市場成長最快的地區，這主要得益於醫藥製造業的快速擴張、學名藥產量的增加以及醫療基礎設施投資的成長。中國和印度等國家正崛起為全球主要的醫藥生產和原料藥（API）中心，從而對高品質輔料產生了巨大的需求。同時，日本和韓國也持續推動創新製劑和生物製藥的研發。預計在預測期內，醫藥出口的擴大、政府支持國內生產的利好政策、契約製造活動的增加以及對口服固體製劑和注射劑需求的成長，將使亞太地區成為成長最快的區域市場。

主要趨勢和促進因素

擴大功能性和新型藥品賦形劑的應用。

醫藥輔料市場正呈現強勁的發展趨勢，即開發和應用多功能新型輔料，以提高藥物穩定性、生物利用度、緩釋效果和患者遵守用藥。製藥公司日益關注先進輔料，例如增溶劑、脂質載體和特殊聚合物，以支持生物製藥、難溶性藥物和標靶給藥系統等複雜製劑的開發。口溶錠、緩釋製劑和注射等創新劑型的拓展，進一步提升了對高性能輔料的需求。此外，監管機構對輔料安全性和品質的日益重視，也推動了生產商對先進製劑技術的投資。

擴大學名藥和製劑的生產

學名藥、專科藥和先進製劑生產的擴張是藥品賦形劑市場的主要驅動力。不斷成長的醫療保健需求、品牌藥專利到期以及醫療系統的成本控制舉措，都促使製藥公司增加學名藥的產量，從而推高了對高品質輔料的需求。此外，生物製藥、營養補充劑和新型給藥系統的快速發展，也催生了對能夠改善藥物性能和穩定性的專用製劑成分的需求。除了新興市場製藥產能的擴張外，研發投入的增加也進一步推動了全球輔料市場的成長。

目錄

第1章摘要整理

第2章 市場亮點

第3章 市場動態

  • 宏觀經濟分析
  • 市場趨勢
  • 市場促進因素
  • 市場機遇
  • 市場限制因素
  • 複合年均成長率分析
  • 影響分析
  • 新興市場
  • 技術藍圖
  • 戰略框架

第4章：細分市場分析

  • 市場規模及預測：依類型
    • 粘合劑
    • 沖淡
    • 崩壞
    • 潤滑劑
    • 塗層劑
    • 香味
    • 防腐劑
    • 著色劑
    • 溶劑
    • 其他
  • 市場規模及預測：依產品分類
    • 有機化學品
    • 無機化學品
    • 其他
  • 市場規模及預測：依類型
    • 固體的
    • 液體
    • 半固體
    • 其他
  • 市場規模及預測：依應用領域分類
    • 口服製劑
    • 外用製劑
    • 注射劑
    • 其他
  • 市場規模及預測：依材料類型分類
    • 聚合物
    • 糖
    • 礦物
    • 明膠
    • 其他
  • 市場規模及預測：依最終用戶分類
    • 製藥公司
    • 生物製藥公司
    • 契約製造組織
    • 其他
  • 市場規模及預測：依功能分類
    • 控釋
    • 即時發布
    • 緩釋
    • 其他
  • 市場規模及預測：依製程分類
    • 顆粒化
    • 直接壓縮
    • 其他
  • 市場規模及預測：依技術分類
    • 奈米科技
    • 微膠囊化
    • 其他

第5章 區域分析

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 拉丁美洲
    • 巴西
    • 阿根廷
    • 其他拉丁美洲國家
  • 亞太地區
    • 中國
    • 印度
    • 韓國
    • 日本
    • 澳洲
    • 台灣
    • 其他亞太國家
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 西班牙
    • 義大利
    • 其他歐洲國家
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非
    • 撒哈拉以南非洲
    • 其他中東和非洲國家

第6章 市場策略

  • 供需差距分析
  • 貿易和物流限制
  • 定價和成本利潤率趨勢
  • 市場滲透率
  • 消費者分析
  • 監管概述

第7章 競爭訊息

  • 市場定位
  • 市場占有率
  • 競爭基準
  • 大公司的策略

第8章：公司簡介

  • BASF
  • Dow Chemical
  • Ashland Global Holdings
  • Evonik Industries
  • DuPont
  • Roquette Freres
  • Kerry Group
  • Colorcon
  • Croda International
  • FMC Corporation
  • JRS Pharma
  • Merck KGaA
  • Eastman Chemical Company
  • Lubrizol Corporation
  • Wacker Chemie AG
  • Archer Daniels Midland Company
  • Associated British Foods
  • Cargill
  • Avantor
  • Ingredion Incorporated

第9章 關於我們

簡介目錄
Product Code: GIS20190

The global Pharmaceutical Excipients Market is projected to grow from $3.9 billion in 2025 to $6.5 billion by 2035, at a compound annual growth rate (CAGR) of 5.3%. The pharmaceutical excipients market is supported by the rising production of medicines, increasing adoption of complex formulations, and growing demand for functional ingredients in oral, injectable, and biologic drug products. According to the U.S. FDA Inactive Ingredient Database (IID), updated in 2025, the database contains thousands of inactive ingredients that have been used in FDA-approved drug products, highlighting the extensive role of excipients in pharmaceutical development. Increasing innovation in modified-release, pediatric, and targeted drug delivery formulations is further driving demand for advanced excipients.

The Type segment of the Pharmaceutical Excipients Market includes binders, diluents, disintegrants, lubricants, coating agents, flavoring agents, preservatives, colorants, solvents, and others. Among these, binders, diluents, and disintegrants account for significant market shares due to their essential role in tablet and capsule formulation, improving drug stability, compressibility, and bioavailability. Coating agents are gaining importance as they enable controlled drug release, protect active ingredients, and enhance product appearance. Solvents, preservatives, and flavoring agents are also witnessing steady demand due to their increasing use in liquid formulations and patient-friendly drug delivery systems. Advancements in formulation technologies and growing demand for complex drug products are further driving innovation in excipient development.

Market Segmentation
TypeBinders, Diluents, Disintegrants, Lubricants, Coating Agents, Flavoring Agents, Preservatives, Colorants, Solvents, Others
ProductOrganic Chemicals, Inorganic Chemicals, Others
TechnologyNanotechnology, Microencapsulation, Others
ApplicationOral Formulations, Topical Formulations, Parenteral Formulations, Others
FormSolid, Liquid, Semi-Solid, Others
Material TypePolymers, Sugars, Minerals, Gelatin, Others
ProcessGranulation, Direct Compression, Others
End UserPharmaceutical Manufacturers, Biopharmaceutical Companies, Contract Manufacturing Organizations, Others
FunctionalityControlled Release, Immediate Release, Sustained Release, Others

The Application segment of the Pharmaceutical Excipients Market includes oral formulations, topical formulations, parenteral formulations, and others. Oral formulations represent the largest application segment due to their widespread adoption, convenience, patient compliance, and cost-effectiveness. The increasing production of tablets, capsules, and oral solid dosage forms is driving demand for functional excipients. Parenteral formulations are experiencing significant growth due to rising demand for biologics, vaccines, and injectable therapies requiring high-quality excipients for stability and safety. Topical formulations are also expanding with increasing applications in dermatology, wound care, and targeted drug delivery. Growing pharmaceutical manufacturing activities globally are supporting market expansion across all application areas.

Geographical Overview

North America held the largest share of the global pharmaceutical excipients market in 2025, driven by its well-established pharmaceutical manufacturing industry, advanced drug formulation capabilities, and strong demand for innovative drug delivery systems. The region is home to leading pharmaceutical companies and excipient manufacturers that continually invest in the development of multifunctional excipients for tablets, capsules, injectables, and biologics. Increasing production of generic drugs, growing adoption of biologics and specialty medicines, and stringent regulatory standards for pharmaceutical quality have further supported market growth. Additionally, continuous investments in research and development, coupled with the rising use of novel excipients to enhance drug stability, bioavailability, and patient compliance, reinforce North America's leading position in the global pharmaceutical excipients market.

Asia Pacific is expected to register the highest growth in the pharmaceutical excipients market due to rapid expansion of pharmaceutical manufacturing, increasing production of generic medicines, and rising investments in healthcare infrastructure. Countries such as China and India have emerged as major global hubs for pharmaceutical production and active pharmaceutical ingredients (APIs), creating significant demand for high-quality excipients. Meanwhile, Japan and South Korea continue to advance the development of innovative drug formulations and biologics. Growing pharmaceutical exports, favorable government initiatives supporting domestic manufacturing, expanding contract manufacturing activities, and increasing demand for oral solid dosage forms and injectable drugs are expected to position Asia Pacific as the fastest-growing regional market throughout the forecast period.

Key Trends and Drivers

Growing Adoption of Functional and Novel Pharmaceutical Excipients:

The Pharmaceutical Excipients Market is witnessing a strong trend toward the development and adoption of multifunctional and novel excipients that enhance drug stability, bioavailability, controlled release, and patient compliance. Pharmaceutical manufacturers are increasingly focusing on advanced excipients such as solubilizers, lipid-based carriers, and specialized polymers to support complex drug formulations, including biologics, poorly soluble drugs, and targeted delivery systems. The growth of innovative dosage forms such as orally disintegrating tablets, sustained-release formulations, and injectable therapies is further increasing demand for high-performance excipients. Additionally, regulatory emphasis on excipient safety and quality is encouraging manufacturers to invest in advanced formulation technologies.

Increasing Production of Generic Drugs and Pharmaceutical Formulations:

The growing production of generic drugs, specialty medicines, and advanced pharmaceutical formulations is a major driver of the Pharmaceutical Excipients Market. Rising healthcare demand, patent expirations of branded drugs, and cost-containment efforts by healthcare systems are encouraging pharmaceutical companies to expand generic drug manufacturing, increasing the need for high-quality excipients. Furthermore, the rapid growth of biologics, nutraceuticals, and novel drug delivery systems is creating demand for specialized formulation ingredients that improve drug performance and stability. Expanding pharmaceutical manufacturing capabilities in emerging economies, along with increasing investments in research and development activities, is further supporting the growth of the excipients market globally.

Research Scope

  • Estimates and forecasts the overall market size across type, application, and region.
  • Provides detailed information and key takeaways on qualitative and quantitative trends, dynamics, business framework, competitive landscape, and company profiling.
  • Identifies factors influencing market growth and challenges, opportunities, drivers, and restraints.
  • Identifies factors that could limit company participation in international markets to help calibrate market share expectations and growth rates.
  • Evaluates key development strategies like acquisitions, product launches, mergers, collaborations, business expansions, agreements, partnerships, and R&D activities.
  • Analyzes smaller market segments strategically, focusing on their potential, growth patterns, and impact on the overall market.
  • Outlines the competitive landscape, assessing business and corporate strategies to monitor and dissect competitive advancements.

Our research scope provides comprehensive market data, insights, and analysis across a variety of critical areas. We cover Local Market Analysis, assessing consumer demographics, purchasing behaviors, and market size within specific regions to identify growth opportunities. Our Local Competition Review offers a detailed evaluation of competitors, including their strengths, weaknesses, and market positioning. We also conduct Local Regulatory Reviews to ensure businesses comply with relevant laws and regulations. Industry Analysis provides an in-depth look at market dynamics, key players, and trends. Additionally, we offer Cross-Segmental Analysis to identify synergies between different market segments, as well as Production-Consumption and Demand-Supply Analysis to optimize supply chain efficiency. Our Import-Export Analysis helps businesses navigate global trade environments by evaluating trade flows and policies. These insights empower clients to make informed strategic decisions, mitigate risks, and capitalize on market opportunities.

TABLE OF CONTENTS

1 Executive Summary

  • 1.1 Market Size and Forecast
  • 1.2 Market Overview
  • 1.3 Market Snapshot
  • 1.4 Regional Snapshot
  • 1.5 Strategic Recommendations
  • 1.6 Analyst Notes

2 Market Highlights

  • 2.1 Key Market Highlights by Type
  • 2.2 Key Market Highlights by Product
  • 2.3 Key Market Highlights by Form
  • 2.4 Key Market Highlights by Application
  • 2.5 Key Market Highlights by Material Type
  • 2.6 Key Market Highlights by End User
  • 2.7 Key Market Highlights by Functionality
  • 2.8 Key Market Highlights by Process
  • 2.9 Key Market Highlights by Technology

3 Market Dynamics

  • 3.1 Macroeconomic Analysis
  • 3.2 Market Trends
  • 3.3 Market Drivers
  • 3.4 Market Opportunities
  • 3.5 Market Restraints
  • 3.6 CAGR Growth Analysis
  • 3.7 Impact Analysis
  • 3.8 Emerging Markets
  • 3.9 Technology Roadmap
  • 3.10 Strategic Frameworks
    • 3.10.1 PORTER's 5 Forces Model
    • 3.10.2 ANSOFF Matrix
    • 3.10.3 4P's Model
    • 3.10.4 PESTEL Analysis

4 Segment Analysis

  • 4.1 Market Size & Forecast by Type (2020-2035)
    • 4.1.1 Binders
    • 4.1.2 Diluents
    • 4.1.3 Disintegrants
    • 4.1.4 Lubricants
    • 4.1.5 Coating Agents
    • 4.1.6 Flavoring Agents
    • 4.1.7 Preservatives
    • 4.1.8 Colorants
    • 4.1.9 Solvents
    • 4.1.10 Others
  • 4.2 Market Size & Forecast by Product (2020-2035)
    • 4.2.1 Organic Chemicals
    • 4.2.2 Inorganic Chemicals
    • 4.2.3 Others
  • 4.3 Market Size & Forecast by Form (2020-2035)
    • 4.3.1 Solid
    • 4.3.2 Liquid
    • 4.3.3 Semi-Solid
    • 4.3.4 Others
  • 4.4 Market Size & Forecast by Application (2020-2035)
    • 4.4.1 Oral Formulations
    • 4.4.2 Topical Formulations
    • 4.4.3 Parenteral Formulations
    • 4.4.4 Others
  • 4.5 Market Size & Forecast by Material Type (2020-2035)
    • 4.5.1 Polymers
    • 4.5.2 Sugars
    • 4.5.3 Minerals
    • 4.5.4 Gelatin
    • 4.5.5 Others
  • 4.6 Market Size & Forecast by End User (2020-2035)
    • 4.6.1 Pharmaceutical Manufacturers
    • 4.6.2 Biopharmaceutical Companies
    • 4.6.3 Contract Manufacturing Organizations
    • 4.6.4 Others
  • 4.7 Market Size & Forecast by Functionality (2020-2035)
    • 4.7.1 Controlled Release
    • 4.7.2 Immediate Release
    • 4.7.3 Sustained Release
    • 4.7.4 Others
  • 4.8 Market Size & Forecast by Process (2020-2035)
    • 4.8.1 Granulation
    • 4.8.2 Direct Compression
    • 4.8.3 Others
  • 4.9 Market Size & Forecast by Technology (2020-2035)
    • 4.9.1 Nanotechnology
    • 4.9.2 Microencapsulation
    • 4.9.3 Others

5 Regional Analysis

  • 5.1 Global Market Overview
  • 5.2 North America Market Size (2020-2035)
    • 5.2.1 United States
      • 5.2.1.1 Type
      • 5.2.1.2 Product
      • 5.2.1.3 Form
      • 5.2.1.4 Application
      • 5.2.1.5 Material Type
      • 5.2.1.6 End User
      • 5.2.1.7 Functionality
      • 5.2.1.8 Process
      • 5.2.1.9 Technology
    • 5.2.2 Canada
      • 5.2.2.1 Type
      • 5.2.2.2 Product
      • 5.2.2.3 Form
      • 5.2.2.4 Application
      • 5.2.2.5 Material Type
      • 5.2.2.6 End User
      • 5.2.2.7 Functionality
      • 5.2.2.8 Process
      • 5.2.2.9 Technology
    • 5.2.3 Mexico
      • 5.2.3.1 Type
      • 5.2.3.2 Product
      • 5.2.3.3 Form
      • 5.2.3.4 Application
      • 5.2.3.5 Material Type
      • 5.2.3.6 End User
      • 5.2.3.7 Functionality
      • 5.2.3.8 Process
      • 5.2.3.9 Technology
  • 5.3 Latin America Market Size (2020-2035)
    • 5.3.1 Brazil
      • 5.3.1.1 Type
      • 5.3.1.2 Product
      • 5.3.1.3 Form
      • 5.3.1.4 Application
      • 5.3.1.5 Material Type
      • 5.3.1.6 End User
      • 5.3.1.7 Functionality
      • 5.3.1.8 Process
      • 5.3.1.9 Technology
    • 5.3.2 Argentina
      • 5.3.2.1 Type
      • 5.3.2.2 Product
      • 5.3.2.3 Form
      • 5.3.2.4 Application
      • 5.3.2.5 Material Type
      • 5.3.2.6 End User
      • 5.3.2.7 Functionality
      • 5.3.2.8 Process
      • 5.3.2.9 Technology
    • 5.3.3 Rest of Latin America
      • 5.3.3.1 Type
      • 5.3.3.2 Product
      • 5.3.3.3 Form
      • 5.3.3.4 Application
      • 5.3.3.5 Material Type
      • 5.3.3.6 End User
      • 5.3.3.7 Functionality
      • 5.3.3.8 Process
      • 5.3.3.9 Technology
  • 5.4 Asia-Pacific Market Size (2020-2035)
    • 5.4.1 China
      • 5.4.1.1 Type
      • 5.4.1.2 Product
      • 5.4.1.3 Form
      • 5.4.1.4 Application
      • 5.4.1.5 Material Type
      • 5.4.1.6 End User
      • 5.4.1.7 Functionality
      • 5.4.1.8 Process
      • 5.4.1.9 Technology
    • 5.4.2 India
      • 5.4.2.1 Type
      • 5.4.2.2 Product
      • 5.4.2.3 Form
      • 5.4.2.4 Application
      • 5.4.2.5 Material Type
      • 5.4.2.6 End User
      • 5.4.2.7 Functionality
      • 5.4.2.8 Process
      • 5.4.2.9 Technology
    • 5.4.3 South Korea
      • 5.4.3.1 Type
      • 5.4.3.2 Product
      • 5.4.3.3 Form
      • 5.4.3.4 Application
      • 5.4.3.5 Material Type
      • 5.4.3.6 End User
      • 5.4.3.7 Functionality
      • 5.4.3.8 Process
      • 5.4.3.9 Technology
    • 5.4.4 Japan
      • 5.4.4.1 Type
      • 5.4.4.2 Product
      • 5.4.4.3 Form
      • 5.4.4.4 Application
      • 5.4.4.5 Material Type
      • 5.4.4.6 End User
      • 5.4.4.7 Functionality
      • 5.4.4.8 Process
      • 5.4.4.9 Technology
    • 5.4.5 Australia
      • 5.4.5.1 Type
      • 5.4.5.2 Product
      • 5.4.5.3 Form
      • 5.4.5.4 Application
      • 5.4.5.5 Material Type
      • 5.4.5.6 End User
      • 5.4.5.7 Functionality
      • 5.4.5.8 Process
      • 5.4.5.9 Technology
    • 5.4.6 Taiwan
      • 5.4.6.1 Type
      • 5.4.6.2 Product
      • 5.4.6.3 Form
      • 5.4.6.4 Application
      • 5.4.6.5 Material Type
      • 5.4.6.6 End User
      • 5.4.6.7 Functionality
      • 5.4.6.8 Process
      • 5.4.6.9 Technology
    • 5.4.7 Rest of APAC
      • 5.4.7.1 Type
      • 5.4.7.2 Product
      • 5.4.7.3 Form
      • 5.4.7.4 Application
      • 5.4.7.5 Material Type
      • 5.4.7.6 End User
      • 5.4.7.7 Functionality
      • 5.4.7.8 Process
      • 5.4.7.9 Technology
  • 5.5 Europe Market Size (2020-2035)
    • 5.5.1 Germany
      • 5.5.1.1 Type
      • 5.5.1.2 Product
      • 5.5.1.3 Form
      • 5.5.1.4 Application
      • 5.5.1.5 Material Type
      • 5.5.1.6 End User
      • 5.5.1.7 Functionality
      • 5.5.1.8 Process
      • 5.5.1.9 Technology
    • 5.5.2 France
      • 5.5.2.1 Type
      • 5.5.2.2 Product
      • 5.5.2.3 Form
      • 5.5.2.4 Application
      • 5.5.2.5 Material Type
      • 5.5.2.6 End User
      • 5.5.2.7 Functionality
      • 5.5.2.8 Process
      • 5.5.2.9 Technology
    • 5.5.3 United Kingdom
      • 5.5.3.1 Type
      • 5.5.3.2 Product
      • 5.5.3.3 Form
      • 5.5.3.4 Application
      • 5.5.3.5 Material Type
      • 5.5.3.6 End User
      • 5.5.3.7 Functionality
      • 5.5.3.8 Process
      • 5.5.3.9 Technology
    • 5.5.4 Spain
      • 5.5.4.1 Type
      • 5.5.4.2 Product
      • 5.5.4.3 Form
      • 5.5.4.4 Application
      • 5.5.4.5 Material Type
      • 5.5.4.6 End User
      • 5.5.4.7 Functionality
      • 5.5.4.8 Process
      • 5.5.4.9 Technology
    • 5.5.5 Italy
      • 5.5.5.1 Type
      • 5.5.5.2 Product
      • 5.5.5.3 Form
      • 5.5.5.4 Application
      • 5.5.5.5 Material Type
      • 5.5.5.6 End User
      • 5.5.5.7 Functionality
      • 5.5.5.8 Process
      • 5.5.5.9 Technology
    • 5.5.6 Rest of Europe
      • 5.5.6.1 Type
      • 5.5.6.2 Product
      • 5.5.6.3 Form
      • 5.5.6.4 Application
      • 5.5.6.5 Material Type
      • 5.5.6.6 End User
      • 5.5.6.7 Functionality
      • 5.5.6.8 Process
      • 5.5.6.9 Technology
  • 5.6 Middle East & Africa Market Size (2020-2035)
    • 5.6.1 Saudi Arabia
      • 5.6.1.1 Type
      • 5.6.1.2 Product
      • 5.6.1.3 Form
      • 5.6.1.4 Application
      • 5.6.1.5 Material Type
      • 5.6.1.6 End User
      • 5.6.1.7 Functionality
      • 5.6.1.8 Process
      • 5.6.1.9 Technology
    • 5.6.2 United Arab Emirates
      • 5.6.2.1 Type
      • 5.6.2.2 Product
      • 5.6.2.3 Form
      • 5.6.2.4 Application
      • 5.6.2.5 Material Type
      • 5.6.2.6 End User
      • 5.6.2.7 Functionality
      • 5.6.2.8 Process
      • 5.6.2.9 Technology
    • 5.6.3 South Africa
      • 5.6.3.1 Type
      • 5.6.3.2 Product
      • 5.6.3.3 Form
      • 5.6.3.4 Application
      • 5.6.3.5 Material Type
      • 5.6.3.6 End User
      • 5.6.3.7 Functionality
      • 5.6.3.8 Process
      • 5.6.3.9 Technology
    • 5.6.4 Sub-Saharan Africa
      • 5.6.4.1 Type
      • 5.6.4.2 Product
      • 5.6.4.3 Form
      • 5.6.4.4 Application
      • 5.6.4.5 Material Type
      • 5.6.4.6 End User
      • 5.6.4.7 Functionality
      • 5.6.4.8 Process
      • 5.6.4.9 Technology
    • 5.6.5 Rest of MEA
      • 5.6.5.1 Type
      • 5.6.5.2 Product
      • 5.6.5.3 Form
      • 5.6.5.4 Application
      • 5.6.5.5 Material Type
      • 5.6.5.6 End User
      • 5.6.5.7 Functionality
      • 5.6.5.8 Process
      • 5.6.5.9 Technology

6 Market Strategy

  • 6.1 Demand-Supply Gap Analysis
  • 6.2 Trade & Logistics Constraints
  • 6.3 Price-Cost-Margin Trends
  • 6.4 Market Penetration
  • 6.5 Consumer Analysis
  • 6.6 Regulatory Snapshot

7 Competitive Intelligence

  • 7.1 Market Positioning
  • 7.2 Market Share
  • 7.3 Competition Benchmarking
  • 7.4 Top Company Strategies

8 Company Profiles

  • 8.1 BASF
    • 8.1.1 Overview
    • 8.1.2 Product Summary
    • 8.1.3 Financial Performance
    • 8.1.4 SWOT Analysis
  • 8.2 Dow Chemical
    • 8.2.1 Overview
    • 8.2.2 Product Summary
    • 8.2.3 Financial Performance
    • 8.2.4 SWOT Analysis
  • 8.3 Ashland Global Holdings
    • 8.3.1 Overview
    • 8.3.2 Product Summary
    • 8.3.3 Financial Performance
    • 8.3.4 SWOT Analysis
  • 8.4 Evonik Industries
    • 8.4.1 Overview
    • 8.4.2 Product Summary
    • 8.4.3 Financial Performance
    • 8.4.4 SWOT Analysis
  • 8.5 DuPont
    • 8.5.1 Overview
    • 8.5.2 Product Summary
    • 8.5.3 Financial Performance
    • 8.5.4 SWOT Analysis
  • 8.6 Roquette Freres
    • 8.6.1 Overview
    • 8.6.2 Product Summary
    • 8.6.3 Financial Performance
    • 8.6.4 SWOT Analysis
  • 8.7 Kerry Group
    • 8.7.1 Overview
    • 8.7.2 Product Summary
    • 8.7.3 Financial Performance
    • 8.7.4 SWOT Analysis
  • 8.8 Colorcon
    • 8.8.1 Overview
    • 8.8.2 Product Summary
    • 8.8.3 Financial Performance
    • 8.8.4 SWOT Analysis
  • 8.9 Croda International
    • 8.9.1 Overview
    • 8.9.2 Product Summary
    • 8.9.3 Financial Performance
    • 8.9.4 SWOT Analysis
  • 8.10 FMC Corporation
    • 8.10.1 Overview
    • 8.10.2 Product Summary
    • 8.10.3 Financial Performance
    • 8.10.4 SWOT Analysis
  • 8.11 JRS Pharma
    • 8.11.1 Overview
    • 8.11.2 Product Summary
    • 8.11.3 Financial Performance
    • 8.11.4 SWOT Analysis
  • 8.12 Merck KGaA
    • 8.12.1 Overview
    • 8.12.2 Product Summary
    • 8.12.3 Financial Performance
    • 8.12.4 SWOT Analysis
  • 8.13 Eastman Chemical Company
    • 8.13.1 Overview
    • 8.13.2 Product Summary
    • 8.13.3 Financial Performance
    • 8.13.4 SWOT Analysis
  • 8.14 Lubrizol Corporation
    • 8.14.1 Overview
    • 8.14.2 Product Summary
    • 8.14.3 Financial Performance
    • 8.14.4 SWOT Analysis
  • 8.15 Wacker Chemie AG
    • 8.15.1 Overview
    • 8.15.2 Product Summary
    • 8.15.3 Financial Performance
    • 8.15.4 SWOT Analysis
  • 8.16 Archer Daniels Midland Company
    • 8.16.1 Overview
    • 8.16.2 Product Summary
    • 8.16.3 Financial Performance
    • 8.16.4 SWOT Analysis
  • 8.17 Associated British Foods
    • 8.17.1 Overview
    • 8.17.2 Product Summary
    • 8.17.3 Financial Performance
    • 8.17.4 SWOT Analysis
  • 8.18 Cargill
    • 8.18.1 Overview
    • 8.18.2 Product Summary
    • 8.18.3 Financial Performance
    • 8.18.4 SWOT Analysis
  • 8.19 Avantor
    • 8.19.1 Overview
    • 8.19.2 Product Summary
    • 8.19.3 Financial Performance
    • 8.19.4 SWOT Analysis
  • 8.20 Ingredion Incorporated
    • 8.20.1 Overview
    • 8.20.2 Product Summary
    • 8.20.3 Financial Performance
    • 8.20.4 SWOT Analysis

9 About Us

  • 9.1 About Us
  • 9.2 Research Methodology
  • 9.3 Research Workflow
  • 9.4 Consulting Services
  • 9.5 Our Clients
  • 9.6 Client Testimonials
  • 9.7 Contact Us